Skip to main content
Addgene

pINS-Puro
(Plasmid #31389)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 31389 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pUNI10, pACYC-184
  • Backbone manufacturer
    Stephen Elledge and Fermentas respectively
  • Backbone size w/o insert (bp) 1869
  • Vector type
    Cre/Lox
  • Selectable markers
    Puromycin

Growth in Bacteria

  • Bacterial Resistance(s)
    Chloramphenicol, 25 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    BW23474
  • Growth instructions
    BW23474 (pir::116), LB 37°C
  • Copy number
    Low Copy

Gene/Insert

  • Gene/Insert name
    pac
  • Alt name
    puromycin-N-acetyl transferase
  • Species
    Streptomyces alboniger
  • Insert Size (bp)
    1441

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site NdeI (not destroyed)
  • 3′ cloning site BamHI (not destroyed)
  • 5′ sequencing primer n/a
  • (Common Sequencing Primers)

Resource Information

  • A portion of this plasmid was derived from a plasmid made by
    Clontech, Carlsbad, CA, USA; Fermentas, Lithuania

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

3nt insert at position 2985 and 1nt mismatch at 2956 of full plasmid sequence. These mutations do not affect function.

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pINS-Puro was a gift from Yegor Vassetzky (Addgene plasmid # 31389 ; http://n2t.net/addgene:31389 ; RRID:Addgene_31389)
  • For your References section:

    A set of vectors for introduction of antibiotic resistance genes by in vitro Cre-mediated recombination. Dmitriev PV, Vassetzky YS. BMC Res Notes. 2008 . 1():135. 10.1186/1756-0500-1-135 PubMed 19105832